This article is more than 5 years old. Information may no longer be current.

Alcon launches CyPass micro-stent at AAO meeting

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CHICAGO — Alcon launched the CyPass micro-stent at the American Academy of Ophthalmology meeting, according to a company press release.

CyPass, approved in July 2016 for use with cataract surgery to lower IOP in adult patients with mild to moderate primary open-angle glaucoma, is implanted during cataract surgery into the supraciliary space, the release said.

“This new treatment option for cataract patients with mild to moderate primary open angle glaucoma has been demonstrated to have a lasting, significant, IOP-lowering effect,” said Sergio Duplan, Alcon’s North American regional president.